fingolimod hydrochloride has been researched along with Infectious Myelitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abouzeid, N; Al-Jumah, M; Alroughani, R; Alsaadi, T; Alsharoqi, I; Bohlega, S; Dahdaleh, M; ElKallab, K; Hashem, S; Inshasi, J; Khoury, S; Tawfeek, T; Yamout, B; Zakaria, M | 1 |
| Maeda, Y; Miyazaki, T; Motomura, M; Nakajima, H; Shiraishi, H; Tanaka, K; Tsujino, A | 1 |
| Chow, WN; Colello, RJ; Graf, MR; Graham, RS; Lee, KD; Mathern, BE; Sato-Bigbee, C; Young, HF | 1 |
3 other study(ies) available for fingolimod hydrochloride and Infectious Myelitis
| Article | Year |
|---|---|
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
Topics: Antibodies, Monoclonal, Humanized; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Middle East; Multiple Sclerosis; Myelitis; Natalizumab; Optic Nerve Diseases; Optic Neuritis; Propylene Glycols; Sphingosine; Spinal Cord Diseases | 2013 |
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Topics: Adolescent; Autoantibodies; Brain; Female; Fingolimod Hydrochloride; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Myelitis; Optic Neuritis; Recurrence; Spinal Cord | 2016 |
FTY720 reduces inflammation and promotes functional recovery after spinal cord injury.
Topics: Animals; Autoimmunity; Chemotaxis, Leukocyte; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Fingolimod Hydrochloride; Flow Cytometry; Immunosuppressive Agents; Lymphocyte Activation; Myelitis; Nerve Fibers, Myelinated; Nerve Regeneration; Paralysis; Propylene Glycols; Rats; Rats, Long-Evans; Recovery of Function; Sphingosine; Spinal Cord Injuries; T-Lymphocytes; Treatment Outcome; Urinary Bladder, Neurogenic; Wallerian Degeneration | 2009 |